Purchase Order 75N91025P00342

Award Date 3/26/25
Potential Completion Date 5/27/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Chelmsford, Chelmsford, MA 01863, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $42,455 firm-fixed-price purchase order to Fluigent, Inc., a foreign-owned for-profit organization, for the procurement of microfluidic equipment for organ-on-a-chip studies. This contract, awarded on July 13, 2024, has a completion date of July 14, 2025 and was not set aside for any specific business category. Fluigent, Inc. is a specialized provider of microfluidic solutions, including automated perfusion systems, pressure generators, and...
The National Institute of Child Health and Human Development, a civilian agency within the Department of Health and Human Services, awarded a $10,520 firm fixed-price purchase order to Fluigent, Inc. for the acquisition of a microfluidics solution exchange system. This contract was set aside for small businesses. Fluigent, Inc. is a foreign-owned, for-profit organization that specializes in microfluidics and fluid handling systems. The company has previously supplied various microfluidic...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services, to Fluigent, Inc., a foreign-owned, for-profit organization specializing in microfluidics and fluid handling systems. The $14,980.00 fixed-price contract is for the procurement of a "PREFUSION SYSTEM", which is likely an advanced microfluidic solution used in biomedical research and scientific studies related to...
This is a $14,701.29 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Fluent Biosciences Inc., a small disadvantaged business. The contract is for the provision of proprietary biological/reagent products to support infectious disease research programs. Fluent Biosciences has also received several federal grants totaling over $7 million from the National...
This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) Genomics and Bioinformatics Research Unit (GBRU) to Fluigent, Inc., a foreign-owned, for-profit microfluidics company, under a small business set-aside. The $24,382.00 contract is for the supply of a microfluidic flow controller, high-pressure reagent reservoir, bidirectional fluid flow sensor, reusable device for producing double emulsion droplets,...
This is a $11,051.62 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Fluent Biosciences Inc., a small disadvantaged business. The contract is for the provision of proprietary biological/reagent products to support NIAID's infectious disease research programs. Fluent Biosciences has also received prior federal grant awards from NIAID and the National Cancer Institute to...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed-price purchase order contract to Fluidic Analytics Inc., a foreign owned, self-certified small disadvantaged business, for the delivery of a FLUIDITY-ONE-M MICROFLUIDIC DIFFUSIONAL SIZING INSTRUMENT. The contract has a potential value of $146,409.00 and a completion date of March 20, 2024. This contract is not associated with a larger vehicle and does not have...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Standard Biotools Inc., doing business as Fluidigm, for the procurement of a C1 single-cell AutoPrep System. The $140,000.00 firm fixed-price purchase order does not have a small business set-aside designation. Fluidigm is an established manufacturer of specialized scientific instruments, reagents, and associated products and services that supports biomedical and environmental research...
This contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $137,800.00, is for a "C1 SYSTEM STANDARD SERVICE PLAN" and was awarded to the prime contractor, Standard Biotools Inc., doing business as Fluidigm. The contract type is a Firm Fixed Price Purchase Order, with a period of performance through March 6, 2021. The contract does not have a small business set-aside...
The Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order contract to Formulatrix, LLC, a foreign-owned for-profit organization, on April 30, 2018. The $79,921.50 contract provides specialized laboratory automation solutions and scientific equipment to support biomedical research efforts, including automated liquid handling systems, protein crystallization imagers and robots,...

This is a $21,710 firm-fixed-price purchase order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Fluigent, Inc., a foreign-owned for-profit organization. The contract is for the delivery of an ARIA Automated Perfusion System, a specialized microfluidic equipment used in advanced scientific research, with a performance period ending on May 27, 2025. The award is not associated with any set-aside program. Fluigent, Inc. has an extensive history of federal contract awards with civilian agencies like NIH, FDA, and USDA, primarily for the provision of cutting-edge microfluidic and fluid handling technologies to support various biomedical research initiatives, including organ-on-a-chip studies, spatial omics research, and COVID-19 related investigations.

Generated 3/28/25, 9:48 AM